Jun 9, 2026 06:06AM
May 19, 2026 04:14AM
May 5, 2026 04:05PM
Apr 27, 2026 07:45AM
Apr 27, 2026 07:45AM
Nov 5, 2025 04:05PM
Oct 3, 2025 08:05AM Stifel Reiterates Buy Rating on Jazz Pharmaceuticals (JAZZ)
Aug 5, 2025 04:05PM
Jun 11, 2025 07:15AM
Jun 10, 2025 07:05AM
Jun 10, 2025 07:05AM
May 6, 2025 04:05PM
Apr 21, 2025 04:05PM
Apr 21, 2025 04:05PM Jazz Pharmaceuticals Completes Acquisition of Chimerix
Mar 6, 2025 07:37AM
Mar 5, 2025 07:02AM
Mar 5, 2025 07:00AM
Nov 21, 2024 07:46AM
Nov 6, 2024 04:05PM
Oct 23, 2024 06:54AM
Sep 16, 2024 07:30AM Jazz Pharmaceuticals (JAZZ) Presents Updated Phase 2 Data for Zanidatamab Demonstrating Increased mPFS in HER2-Positive Metastatic Gastroesophageal Adenocarcinoma at ESMO
Sep 16, 2024 07:30AM
Sep 11, 2024 07:11AM
Sep 9, 2024 07:58AM
Aug 1, 2024 06:26AM
Jul 31, 2024 04:05PM
Jun 5, 2024 02:23AM
Jun 1, 2024 08:05AM Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024
May 29, 2024 02:21PM
May 29, 2024 07:45AM
May 29, 2024 07:45AM
May 7, 2024 04:00PM
Nov 8, 2023 04:01PM
Aug 8, 2023 04:01PM
Aug 3, 2021 04:05PM Jazz Pharmaceuticals Announces Second Quarter 2021 Financial Results
Jun 25, 2021 07:45AM
Jun 25, 2021 07:45AM
Jun 9, 2021 07:45AM
May 4, 2021 04:51PM
May 4, 2021 04:05PM
Apr 19, 2021 07:42AM
Apr 12, 2021 07:46AM Jazz Pharmaceuticals (JAZZ) Reports FDA Acceptance and Priority Review of Supplemental NDA for Xywav Oral Solution in Idiopathic Hypersomnia
Apr 12, 2021 07:45AM
May 5, 2020 04:17PM
May 5, 2020 04:05PM
Mar 31, 2020 04:02PM
Mar 31, 2020 04:01PM
Mar 25, 2020 04:10PM
Mar 25, 2020 04:05PM Jazz Pharmaceuticals Announces FDA Acceptance of New Drug Application for JZP-258 for Cataplexy and Excessive Daytime Sleepiness Associated with Narcolepsy
Feb 25, 2020 04:05PM

15,472 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All